Figure EV1. The m⁶A modification landscape of EBV in NPC cells, B cells, and tissue samples.

The m⁶A modification landscape of EBV in different cells with different stages of EBV infection is shown. The data presented from the top down are EBV acute infection in NPEC1‐Bmi1 sphere‐like cells; EBV acute infection in HK1 cells; EBV latent infection in C666 cells; CNE2EBV cells with latent infection, induced with TPA, induced with NaB, induced with both TPA and NaB; PDX‐NPC04L tissue; PDX‐NPC03W tissue; NPC1 tissue; NPC2 tissue; nontumor control biopsy (NPN); B95‐8 cells with latent EBV infection, reactivated with TPA and NaB at 24 h, or 48 h; Raji cells with EBV latent infection, reactivated with TPA and NaB at 24 h, or 48 h; Akata cells with EBV latent infection, reactivated with IgG at 24 h, or 48 h. The input and MeRIP coverage is indicated with blue and pink bars, respectively.